Skip to main content
Premium Trial:

Request an Annual Quote

Signature Diagnostics Licenses Genedata s Expressionist Tool

NEW YORK, Nov. 1 (GenomeWeb News) - Genedata has licensed its Expressionist tool to Signature Diagnostics to create gene profiles in colorectal cancer patients, Genedata said today.

 

Signature Diagnostics will use the Expressionist software to process and analyze Affymetrix GeneChip data from thousands of CRC patients currently receiving treatment, Genedata said. The goal is to identify unique gene-expression signatures that predict the risk of recurrence and response to therapy of individual patients.

 

Signature Diagnostics, based in Potsdam, Germany, collaborates with clinical partners to improve the clinical development of oncology drugs and develops molecular diagnostics for predicting outcome and drug response in cancer patients.

 

Additional details for the licensing agreement were not disclosed.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.